A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries

Table 3 Liposomal amphotericin B tiered prices (prices in USD ($)

	Average unit price (year)*		Average treatment cost (year)
Liposomal amphotericin B	Gilead	Lowest generic (Cipla VL price)	Gilead	Lowest generic (Cipla VL price)
WHO	18 (2009)	25 (2008)	252 (2009)	350 (2008)
	20 (2006)		280 (2006)
	50 (1991)		700^† (1991)
UK private market	153 (2010)		2,142 (2010)

*Currency converted using http://www.oanda.com on 13 December 2010.
^† Based on an average weight of 35 kg for a patient with visceral leishmaniasis, 14 vials are required for a full treatment course.
VL = visceral leishmaniasis.
Sources: personal communication, G. Alton, 2009.

ISSN: 1744-8603